Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

NCT00405301 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
175
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

All India Institute of Medical Sciences